SEC-sourced researchBeta
MED
MEDIFAST INC
Company comparison ↗
Data passport
- CIK
- 0000910329
- Exchange
- NYSE
- Business activity
- — · SIC 2090
- Financial inputs
- 6/6
- Filing date
- Sep 30, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 1,072,054,000.0000 | Feb 17, 2026 |
| December 2024 | 602,463,000.0000 | Feb 17, 2026 |
| December 2025 | 385,788,000.0000 | Feb 17, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 385,788,000.0000 | -18,672,000.0000 | 6,863,000.0000 | 247,973,000.0000 | 49,053,000.0000 | Feb 17, 2026 |
| December 2024 | 602,463,000.0000 | 2,091,000.0000 | 24,476,000.0000 | 284,213,000.0000 | 74,104,000.0000 | Feb 17, 2026 |
| December 2023 | 1,072,054,000.0000 | 99,415,000.0000 | 147,657,000.0000 | — | — | Feb 17, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $385.79M | December 2025 | Feb 17, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $602.46M | December 2024 | Feb 17, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$18.67M | December 2025 | Feb 17, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $6.86M | December 2025 | Feb 17, 2026 | 10-K |
| Total assetsAssets | $247.97M | December 2025 | Feb 17, 2026 | 10-K |
| Total liabilitiesLiabilities | $49.05M | December 2025 | Feb 17, 2026 | 10-K |